Righi N, SLIMANI S, Mansouri O-K, Badla Y, Aithamouda R.
Manifestations rhumatismales du virus de l’immunodéficience humaine. Rev Mar Rhum 2015Rev Mar Rhum 2015. 2015;31 :27-33.
Righi N, SLIMANI S, Mansouri O-K, Badla Y, Aithamouda R.
Manifestations rhumatismales du virus de l’immunodéficience humaine. Rev Mar Rhum 2015Rev Mar Rhum 2015. 2015;31 :27-33.
Righi N, SLIMANI S, Mansouri O-K, Badla Y, Aithamouda R.
Manifestations rhumatismales du virus de l’immunodéficience humaine. Rev Mar Rhum 2015Rev Mar Rhum 2015. 2015;31 :27-33.
Righi N, SLIMANI S, Mansouri O-K, Badla Y, Aithamouda R.
Manifestations rhumatismales du virus de l’immunodéficience humaine. Rev Mar Rhum 2015Rev Mar Rhum 2015. 2015;31 :27-33.
Righi N, SLIMANI S, Mansouri O-K, Badla Y, Aithamouda R.
Manifestations rhumatismales du virus de l’immunodéficience humaine. Rev Mar Rhum 2015Rev Mar Rhum 2015. 2015;31 :27-33.
Salah Z, Arafeh R, Maximov V, Galasso M, Khawaled S, Abou-Sharieha S, Volinia S, Jones KB, Croce CM, Aqeilan RI.
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells. OncotargetOncotarget. 2015;6 :4920.
Salah Z, Arafeh R, Maximov V, Galasso M, Khawaled S, Abou-Sharieha S, Volinia S, Jones KB, Croce CM, Aqeilan RI.
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells. OncotargetOncotarget. 2015;6 :4920.
Salah Z, Arafeh R, Maximov V, Galasso M, Khawaled S, Abou-Sharieha S, Volinia S, Jones KB, Croce CM, Aqeilan RI.
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells. OncotargetOncotarget. 2015;6 :4920.
Salah Z, Arafeh R, Maximov V, Galasso M, Khawaled S, Abou-Sharieha S, Volinia S, Jones KB, Croce CM, Aqeilan RI.
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells. OncotargetOncotarget. 2015;6 :4920.
Salah Z, Arafeh R, Maximov V, Galasso M, Khawaled S, Abou-Sharieha S, Volinia S, Jones KB, Croce CM, Aqeilan RI.
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells. OncotargetOncotarget. 2015;6 :4920.
Salah Z, Arafeh R, Maximov V, Galasso M, Khawaled S, Abou-Sharieha S, Volinia S, Jones KB, Croce CM, Aqeilan RI.
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells. OncotargetOncotarget. 2015;6 :4920.
Salah Z, Arafeh R, Maximov V, Galasso M, Khawaled S, Abou-Sharieha S, Volinia S, Jones KB, Croce CM, Aqeilan RI.
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells. OncotargetOncotarget. 2015;6 :4920.
Salah Z, Arafeh R, Maximov V, Galasso M, Khawaled S, Abou-Sharieha S, Volinia S, Jones KB, Croce CM, Aqeilan RI.
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells. OncotargetOncotarget. 2015;6 :4920.
Salah Z, Arafeh R, Maximov V, Galasso M, Khawaled S, Abou-Sharieha S, Volinia S, Jones KB, Croce CM, Aqeilan RI.
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells. OncotargetOncotarget. 2015;6 :4920.
Salah Z, Arafeh R, Maximov V, Galasso M, Khawaled S, Abou-Sharieha S, Volinia S, Jones KB, Croce CM, Aqeilan RI.
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells. OncotargetOncotarget. 2015;6 :4920.